Reuters: Health News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
FDA declines to approve Pfizer biosimilar of Roche's cancer drug
23 Apr 2018 at 5:28am
(Reuters) - Pfizer Inc said on Monday U.S. regulators declined to approve the company's biosimilar of Roche's blockbuster treatment for breast cancer, Herceptin, and sought additional technical information.
Woodford-backed biotech Prothena plunges as key drug fails
23 Apr 2018 at 6:59am
LONDON (Reuters) - Shares in Prothena, a biotech company backed by British investor Neil Woodford, plunged 70 percent on Monday after its main drug for treating a rare disease called AL amyloidosis failed in a crucial clinical trial.
Trump delays drug pricing speech, no set date yet
23 Apr 2018 at 7:16am
WASHINGTON (Reuters) - U.S. President Donald Trump has postponed a speech on lowering prescription drug prices previously scheduled for Thursday to a date in the near future, the White House said on Sunday.
Jilted Akorn sues Fresenius over deal termination
23 Apr 2018 at 7:50am
FRANKFURT (Reuters) - U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled their $4.75 billion takeover agreement.
U.S. appeals court blocks Indiana 'selective' abortion law
19 Apr 2018 at 5:37pm
(Reuters) - A federal appeals court on Thursday declared unconstitutional an Indiana law signed by then-Governor Mike Pence that banned women from having abortions because of the gender, race or disability, including Down's syndrome, of their fetuses.
Biogen boosts investment in neurology with $1 billion Ionis deal
20 Apr 2018 at 8:40am
(Reuters) - Biogen Inc struck a $1 billion neurology drug development deal with Ionis Pharmaceuticals on Friday, expanding a partnership that developed the company's potential blockbuster drug for spinal muscular atrophy.
Germany's Merck seeks partners for cancer and immune system drugs
20 Apr 2018 at 6:14am
FRANKFURT (Reuters) - Merck KGaA will seek development partners for experimental treatments including tepotinib as the German company looks to licensing deals to help fund clinical trials, according to its head of drug R&D.
Novartis CEO feels heat on U.S. generics, Cosentyx drop
19 Apr 2018 at 5:06am
ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit.
Hungarian laboratory worker isolated after exposure to Ebola virus
20 Apr 2018 at 1:06pm
BUDAPEST (Reuters) - A Hungarian laboratory worker has been isolated at a Budapest hospital after accidental exposure to the deadly Ebola virus but has shown no symptoms so far, health officials said on Friday.
U.S. biotech companies Alnylam, Dicerna settle trade secrets case
20 Apr 2018 at 10:55am
BOSTON (Reuters) - Alnylam Pharmaceuticals Inc said on Friday that Dicerna Pharmaceuticals Inc will pay it $25 million in cash and stock to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.